Clinical Trial Update: Intravitreal Aflibercept in Wet Age Related Macular Degeneration Patients With an Incomplete Response to Routine Ranibizumab Injections [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating intravitreal aflibercept for patients with incomplete response to ranibizumab in wet age-related macular degeneration; the stu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration

Drugs mentioned

• Aflibercept (Aflibercept)
• Ranibizumab (ranibizumab)

Snippet

Sponsor: Unity Health Toronto | Conditions: Age Related Macular Degeneration | Phase 4 | Status: TERMINATED